Author： Chu Micheline C. Rath Kristina M. Huie Jennifer Taylor Hugh S.
Publisher： Oxford University Press
ISSN： 1460-2350
Source： Human Reproduction, Vol.18, Iss.8, 2003-08, pp. : 1570-1573
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
BACKGROUND: Cardiovascular disease is the leading cause of death in women, with most deaths occurring after menopause. It had been assumed that lack of estrogen is a leading contributing factor to cardiovascular disease in women. Recent trials, however, using hormone replacement therapy to treat cardiovascular disease in women have not affirmed the cardiovascular benefits ascribed to this regimen. Ovarian function declines slowly over the decades approaching the menopause as evidenced by declining fertility, rising serum FSH, falling inhibin, yet normal estradiol levels. We investigated the relationship between basal FSH and an established major risk factor for cardiovascular disease. METHODS AND RESULTS: We obtained cycle day 3 serum FSH levels and fasting lipoprotein profiles on 40 women between the ages of 29 and 49 years, with normal menstrual cycles and who were not using hormonal medications or statins. Premenopausal women with an FSH level ≥7 IU/l had significantly elevated total cholesterol (P = 0.009) and LDL (P = 0.019) compared with those with FSH <7 iu/l.="" this="" difference="" was="" independent="" of="" age.="" neither="" hdl="" nor="" triglyceride="" levels="" differed="" between="" the="" two="" groups.="" conclusions:="" decreased="" functional="" ovarian="" reserve,="" as="" approximated="" by="" serum="" day="" 3="" fsh="" levels,="" correlates="" with="" known="" cardiovascular="" risk="" factors.="" declining="" ovarian="" function="" prior="" to="" estrogen="" deficiency="" may="" be="" a="" cardiac="" risk="" factor.="" the="" premenopausal="" ovary="" may="" be="" a="" source="" of="" cardioprotective="" substance="" other="" than="" estradiol.="" we="" hypothesize="" that="" factors="" other="" than="" 17‐estradiol,="" but="" related="" to="" ovarian="" function,="" might="" contribute="" to="" cardiovascular="" risk.="">
Related content
Access to resources
Recommend
By de Koning C.H. Benjamins T. Harms P. Homburg R. van Montfrans J.M. Gromoll J. Simoni M. Lambalk C.B.
Human Reproduction, Vol. 21, Iss. 2, 2006-02 ,pp. :
By Brodin Thomas Bergh Torbjrn Berglund Lars Hadziosmanovic Nermin Holte Jan
Human Reproduction, Vol. 24, Iss. 11, 2009-11 ,pp. :
By Guzelmeric Kadir Alkan Nevriye Pirimoglu Meltem Unal Orhan Turan Cem
Gynecological Endocrinology, Vol. 23, Iss. 9, 2007-09 ,pp. :